ETHYOL Side Effects

5378258-4 | Atrial Fibrillation, Blood Potassium Decreased, Blood Sodium Decreased, Blood Urea Increased, Brain Natriuretic Peptide Increased, Burns Second Degree, Cardiac Enzymes Increased, Dehydration
on Jun 25, 2007 Female patient from UNITED STATES , 65 years of age, weighting 185.0 lb, was diagnosed with neoplasm malignant and was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), blood potassium decreased, blood sodium decreased, blood urea increased, brain natriuretic peptide increased, burns second degree, cardiac enzymes increased, dehydration. Ethyol dosage: 500 Mg, 5 In 5 D, Subcutaneous. During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOCOR (View Zocor Review and Zocor Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

5378257-2 | Anorexia, Cardio-respiratory Arrest, Diarrhoea, Pulmonary Embolism
Patient was taking Ethyol (View Usage). Patient had the following side effects: anorexia, cardio-respiratory arrest, diarrhoea, pulmonary embolism (What is pulmonary embolism?) on Jun 20, 2007 from UNITED STATES Additional patient health information: Female patient , 73 years of age, . Ethyol dosage: 500 Mg, 1 In 1 D, Subcutaneous. During the same period patient was treated with XELODA (CAPECITABINE) (CAPECITABINE) (View Xeloda (capecitabine) (capecitabine) Review and Xeloda (capecitabine) (capecitabine) Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), COMPAZINE (PROCHLORERAZINE) (PROCHLORPERAZINE EDISYLATE) (View Compazine (prochlorerazine) (prochlorperazine Edisylate) Review and Compazine (prochlorerazine) (prochlorperazine Edisylate) Label ), L THYROXINE (LEVOTHYROXINE) (LEVOTHYROXINE) (View L-thyroxine (levothyroxine) (levothyroxine) Review and L-thyroxine (levothyroxine) (levothyroxine) Label ), PRINZIDE (View Prinzide Review and Prinzide Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), ANZEMET (DOLASETRON MESILATE) (DOLASETRON MESILATE) (View Anzemet (dolasetron Mesilate) (dolasetron Mesilate) Review and Anzemet (dolasetron Mesilate) (dolasetron Mesilate) Label ). Patient was hospitalized.

5373190-4 | Anaphylactoid Reaction, Back Pain, Dermatitis Exfoliative, Diarrhoea, Hypotension, Platelet Count Decreased, Toxic Epidermal Necrolysis, White Blood Cell Count Decreased
Adverse event was reported on Jun 13, 2007 by a Male patient taking Ethyol (View Usage) (Dosage: 500 Mg, 5 In 5 D, Subcutaneous) was diagnosed with prophylaxis, rectal cancer and. Location: UNITED STATES , 52 years of age, weighting 172.0 lb, After Ethyol was administered, patient had the following side effects: anaphylactoid reaction, back pain (What is back pain?), dermatitis exfoliative, diarrhoea, hypotension, platelet count decreased, toxic epidermal necrolysis, white blood cell count decreased. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5373189-8 | Atrial Fibrillation, Radiation Mucositis, Urinary Tract Infection
on Jun 13, 2007 Female patient from UNITED STATES , 65 years of age, weighting 185.0 lb, was diagnosed with neoplasm malignant and was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), radiation mucositis, urinary tract infection (What is urinary tract infection?). Ethyol dosage: 500 Gm, 5 In 5 D, Subcutaneous. During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOCOR (View Zocor Review and Zocor Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.


5373188-6 | Breath Sounds Abnormal, Diarrhoea, Hypotension, Pain In Extremity, Pulmonary Embolism, Sepsis Syndrome
on Jun 13, 2007 Female patient from UNITED STATES , 82 years of age, was treated with Ethyol (View Usage). Patient had the following side effects: breath sounds abnormal, diarrhoea, hypotension, pain in extremity, pulmonary embolism (What is pulmonary embolism?), sepsis syndrome. Ethyol dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

5361717-8 | Pruritus, Rash Maculo-papular
Patient was taking Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: pruritus, rash maculo-papular on Jun 15, 2007 from UNITED STATES Additional patient health information: Male patient , 49 years of age, was diagnosed with dry mouth and. Ethyol dosage: Daily M-f 500mg Sq X 6.

5361109-1 | Blood Pressure Decreased, Chills, Haematuria, Mucosal Erosion, Pyrexia, Radiation Injury
Adverse event was reported on Jun 04, 2007 by a Female patient taking Ethyol (View Usage) (Dosage: 500 Mg, 5 In 5 D, Subcutaneous) was diagnosed with neoplasm malignant and. Location: UNITED STATES , 65 years of age, weighting 407.9 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, chills, haematuria, mucosal erosion, pyrexia, radiation injury. During the same period patient was treated with PRINIVIL (View Prinivil Review and Prinivil Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOCOR (View Zocor Review and Zocor Label ), COUMADIN (View Coumadin Review and Coumadin Label ), NORVASC (View Norvasc Review and Norvasc Label ), KYTRIL (View Kytril Review and Kytril Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ). Patient was hospitalized.

5355433-6 | Body Temperature Increased, Rash Maculo-papular
on Jun 11, 2007 Male patient from UNITED STATES , 56 years of age, weighting 155.5 lb, was diagnosed with dry mouth and was treated with Ethyol (View Usage). Patient had the following side effects: body temperature increased, rash maculo-papular. Ethyol dosage: 500 Mg Sq M-f X 6.

5352980-8 | Injection Site Rash
on May 30, 2007 Male patient from UNITED STATES , 69 years of age, weighting 159.5 lb, was treated with Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: injection site rash. Ethyol dosage: 500 Mg, 1 In 1 D, Subcutaneous. During the same period patient was treated with ESOPHAGITIS MIXTURE (View Esophagitis Mixture Review and Esophagitis Mixture Label ), LUNESTA (View Lunesta Review and Lunesta Label ), MARY'S MAGIC MOUTHWASH (View Mary's Magic Mouthwash Review and Mary's Magic Mouthwash Label ), NEXIUM (View Nexium Review and Nexium Label ), THORAZINE (View Thorazine Review and Thorazine Label ), TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.

5352383-6 | Agranulocytosis, Bronchial Obstruction, Corneal Perforation, Dermatitis Exfoliative, Disturbance In Attention, Dysphagia, Erythema, Fall, Haemodynamic Instability
Patient was taking Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, bronchial obstruction, corneal perforation, dermatitis exfoliative, disturbance in attention, dysphagia, erythema, fall (What is fall?), haemodynamic instability on May 25, 2007 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with prophylaxis, infection (What is infection?), nausea (What is nausea?) and. Ethyol dosage: 340 Mg, 3 In 1 Wk, Intravenous (not Otherwise Specified). During the same period patient was treated with CIPROFLOXACIN (Oral) (View Ciprofloxacin Review and Ciprofloxacin Label ), AUGMENTIN '125' (Intravenous (not Otherwise Specified)) (View Augmentin '125' Review and Augmentin '125' Label ), FLUCONAZOLE (Intravenous (not Otherwise Specified)) (View Fluconazole Review and Fluconazole Label ), ACETAMINOPHEN (Intravenous (not Otherwise Specified)) (View Acetaminophen Review and Acetaminophen Label ), PRIMPERAN TAB (Intravenous (not Otherwise Specified)) (View Primperan Tab Review and Primperan Tab Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized and became disabled.

5343691-3 | Chills, Dyspnoea, Injection Site Erythema, Injection Site Rash, Pyrexia, Tremor
Adverse event was reported on May 17, 2007 by a Male patient taking Ethyol (View Usage) (Dosage: See Imate) . Location: UNITED STATES , 69 years of age, weighting 159.5 lb, Patient had the following side effects: chills, dyspnoea, injection site erythema, injection site rash, pyrexia, tremor. During the same period patient was treated with ESOPHAGITIS MIXTURE (View Esophagitis Mixture Review and Esophagitis Mixture Label ), LUNESTA (View Lunesta Review and Lunesta Label ), MARY'S MAGIC MOUTHWASH (View Mary's Magic Mouthwash Review and Mary's Magic Mouthwash Label ), NEXIUM (View Nexium Review and Nexium Label ), THORAZINE (View Thorazine Review and Thorazine Label ), TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.

5343689-5 | Asthenia, Body Temperature Increased, Chills, Fatigue, Flushing, Hypotension, Injection Site Erythema, Malaise, Nausea
on May 17, 2007 Female patient from UNITED STATES , 53 years of age, weighting 172.0 lb, was treated with Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: asthenia, body temperature increased, chills, fatigue, flushing, hypotension, injection site erythema, malaise, nausea (What is nausea?). Ethyol dosage: See Image. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), ACTIVELLA (View Activella Review and Activella Label ), ALLEGRA (View Allegra Review and Allegra Label ), ATIVAN (View Ativan Review and Ativan Label ), CALCIUM WITH VITAMIN D (COLECALCIFEROL, CALCIUM CARBONATE) (View Calcium With Vitamin D (colecalciferol, Calcium Carbonate) Review and Calcium With Vitamin D (colecalciferol, Calcium Carbonate) Label ), CARAFATE (View Carafate Review and Carafate Label ). Patient was hospitalized.

5339886-5 | Chills, Dermatitis Exfoliative, Diarrhoea, Hypotension, Nausea, Petechiae, Pyrexia, Rash
on May 14, 2007 Male patient from UNITED STATES , 52 years of age, weighting 172.0 lb, was diagnosed with prophylaxis, rectal cancer and was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: chills, dermatitis exfoliative, diarrhoea, hypotension, nausea (What is nausea?), petechiae, pyrexia, rash (What is rash?). Ethyol dosage: 500 Mg, 5 In 5 D, Subcutaneous. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5328637-6 | Adhesion, Agranulocytosis, Bronchial Obstruction, Catheter Site Infection, Corneal Perforation, Depressed Level Of Consciousness, Dermatitis Exfoliative, Dysphagia, Eyelid Disorder
Patient was taking Ethyol (View Usage). Patient had the following side effects: adhesion (What is adhesion?), agranulocytosis, bronchial obstruction, catheter site infection, corneal perforation, depressed level of consciousness, dermatitis exfoliative, dysphagia, eyelid disorder on May 01, 2007 from FRANCE Additional patient health information: Male patient , 68 years of age, was diagnosed with prophylaxis, infection (What is infection?), nausea (What is nausea?) and. Ethyol dosage: 340 Mg, 3 In 1 Wk, Intravenous. During the same period patient was treated with CIPROFLOXACIN (Oral) (View Ciprofloxacin Review and Ciprofloxacin Label ), AUGMENTIN '125' (Intravenous) (View Augmentin '125' Review and Augmentin '125' Label ), FLUCONAZOLE (Intravenous) (View Fluconazole Review and Fluconazole Label ), PERFALGAN (PARACETAMOL) (Intravenous) (View Perfalgan (paracetamol) Review and Perfalgan (paracetamol) Label ), PRIMPERAN TAB (Intravenous) (View Primperan Tab Review and Primperan Tab Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized and became disabled.

5328095-1 | Asthenia, Sepsis, Vomiting
Adverse event was reported on May 01, 2007 by a Male patient taking Ethyol (View Usage) (Dosage: 500 Mg, 5 In 5 D, Subcutaneous) was diagnosed with laryngeal cancer and. Location: UNITED STATES , 26 years of age, weighting 262.0 lb, After Ethyol was administered, patient had the following side effects: asthenia, sepsis (What is sepsis?), vomiting. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

5318518-6 | Adhesion, Agranulocytosis, Blood Culture, Conjunctival Oedema, Corneal Disorder, Corneal Perforation, Dermatitis Exfoliative, Disturbance In Attention, Dysphagia
on Apr 19, 2007 Male patient from FRANCE , 68 years of age, was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: adhesion (What is adhesion?), agranulocytosis, blood culture, conjunctival oedema, corneal disorder, corneal perforation, dermatitis exfoliative, disturbance in attention, dysphagia. Ethyol dosage: 340 Mg, 3 In1 Wk, Intravenous (not Otherwise Specified). During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), (PARACETAMOL, TRAMADOL HYDROCHLORIDE) (View (paracetamol, Tramadol Hydrochloride) Review and (paracetamol, Tramadol Hydrochloride) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5318436-3 | Asthenia, Atrial Fibrillation, Escherichia Infection, Gastrointestinal Necrosis, Hypertension, Ileus, Intestinal Ischaemia, Peritonitis Bacterial, Post Procedural Complication
on Apr 19, 2007 Female patient from UNITED STATES , 70 years of age, was treated with Ethyol (View Usage). Patient had the following side effects: asthenia, atrial fibrillation (What is atrial fibrillation?), escherichia infection, gastrointestinal necrosis, hypertension, ileus, intestinal ischaemia, peritonitis bacterial, post procedural complication. Ethyol dosage: . During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

5318435-1 | Chills, Erythema, Injection Site Erythema, Malaise, Oral Mucosa Erosion, Pain Of Skin, Pharyngolaryngeal Pain, Pyrexia, Radiation Injury
Patient was taking Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: chills, erythema, injection site erythema, malaise, oral mucosa erosion, pain of skin, pharyngolaryngeal pain, pyrexia, radiation injury on Apr 18, 2007 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 262.0 lb, was diagnosed with prophylaxis and. Ethyol dosage: . During the same period patient was treated with INTERFERON (INTERFERON) (View Interferon (interferon) Review and Interferon (interferon) Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), SALAGEN (View Salagen Review and Salagen Label ), COMPAZINE (View Compazine Review and Compazine Label ), CAPITOL W/CODEINE (CODEINE PHOSPHATE, PARACTAMOL) (View Capitol W/codeine (codeine Phosphate, Paractamol) Review and Capitol W/codeine (codeine Phosphate, Paractamol) Label ). Patient was hospitalized.

5318434-X | Anxiety, Arthralgia, Blister, Burning Sensation, Chills, Diarrhoea, Dry Skin, Erythema
Adverse event was reported on Apr 19, 2007 by a Male patient taking Ethyol (View Usage) (Dosage: See Image) was diagnosed with adenocarcinoma and. Location: UNITED STATES , 63 years of age, weighting 268.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), arthralgia, blister, burning sensation, chills, diarrhoea, dry skin, erythema. During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE, TRIAMTERENE) (View Triamterene And Hydrochlorothiazide (hydrochlorothiazide, Triamterene) Review and Triamterene And Hydrochlorothiazide (hydrochlorothiazide, Triamterene) Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ACETAMINOPHEN AND OXYCODONE HCL (View Acetaminophen And Oxycodone Hcl Review and Acetaminophen And Oxycodone Hcl Label ), ALLEGRA (View Allegra Review and Allegra Label ), KYTRIL (View Kytril Review and Kytril Label ).

5318179-6 | Hypotension, Injection Site Erythema, Neutropenia, Pyrexia, Sneezing
on Aug 29, 2006 Female patient from UNITED STATES , 62 years of age, weighting 147.0 lb, was treated with Ethyol (View Usage). Patient had the following side effects: hypotension, injection site erythema, neutropenia, pyrexia, sneezing. Ethyol dosage: 5 In 1 Wk, Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PREMARIN (View Premarin Review and Premarin Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ). Patient was hospitalized.

5318178-4 | Renal Failure Acute
on Nov 14, 2006 Female patient from UNITED STATES , 69 years of age, was treated with Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: renal failure acute. Ethyol dosage: 500 Mg, 5 In 5 D, Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

5318169-3 | Depressed Level Of Consciousness, Hypotension
Patient was taking Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, hypotension on Nov 13, 2006 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 132.0 lb, . Ethyol dosage: Subcutaneous. During the same period patient was treated with CADUET (ATORVASTATIN CALCIUM, AMLODIPINE BESILATE) (View Caduet (atorvastatin Calcium, Amlodipine Besilate) Review and Caduet (atorvastatin Calcium, Amlodipine Besilate) Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AVALIDE (View Avalide Review and Avalide Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

5318160-7 | Cardio-respiratory Arrest
Adverse event was reported on Oct 26, 2006 by a Female patient taking Ethyol (View Usage) (Dosage: 500 Mg, 5 In 5 D, Intravenous Bolus) . Location: UNITED STATES , 71 years of age, weighting 155.4 lb, Patient had the following side effects: cardio-respiratory arrest. During the same period patient was treated with LORTAB (View Lortab Review and Lortab Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), OVER THE COUNTER COUGH SYRUP (View Over-the-counter Cough Syrup Review and Over-the-counter Cough Syrup Label ). Patient was hospitalized.

5318158-9 | Pyrexia, Stomatitis
on Aug 23, 2006 Female patient from UNITED STATES , 62 years of age, weighting 153.0 lb, was treated with Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: pyrexia, stomatitis. Ethyol dosage: See Image. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), DECADRON (View Decadron Review and Decadron Label ), ALOXI (View Aloxi Review and Aloxi Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

5318131-0 | Dehydration, Diarrhoea, Pyrexia, Vomiting
on Aug 21, 2006 Male patient from UNITED STATES , 64 years of age, weighting 166.0 lb, was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, pyrexia, vomiting. Ethyol dosage: See Image. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), KYRTIL (GRANISETRON) (View Kyrtil (granisetron) Review and Kyrtil (granisetron) Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ). Patient was hospitalized.

5318115-2 | Dyspepsia, Haemophilus Infection, Herpes Zoster, Hyperhidrosis, Hypertension, Nausea, Pyrexia
Patient was taking Ethyol (View Usage). Patient had the following side effects: dyspepsia, haemophilus infection, herpes zoster, hyperhidrosis, hypertension, nausea (What is nausea?), pyrexia on Jul 12, 2006 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 182.0 lb, . Ethyol dosage: 5 In 5 D, Subcutaneous. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), COZAAR (View Cozaar Review and Cozaar Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), FLONASE (View Flonase Review and Flonase Label ). Patient was hospitalized.

5318112-7 | Tachycardia
Adverse event was reported on May 11, 2006 by a Female patient taking Ethyol (View Usage) (Dosage: 1 In 1 D, Subcutaneous) . Location: UNITED STATES , 37 years of age, After Ethyol was administered, patient had the following side effects: tachycardia. Patient was hospitalized.

5318083-3 | Adjustment Disorder, Asthenia, Chills, Constipation, Fatigue, Nausea, Oral Pain, Rash, Stomatitis
on Mar 15, 2006 Male patient from UNITED STATES , 50 years of age, was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: adjustment disorder, asthenia, chills, constipation (What is constipation?), fatigue, nausea (What is nausea?), oral pain, rash (What is rash?), stomatitis. Ethyol dosage: Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ALLEGRA (View Allegra Review and Allegra Label ), KYTRIL (View Kytril Review and Kytril Label ), COMPAZINE (View Compazine Review and Compazine Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

5318080-8 | Injection Site Reaction
on Jul 05, 2006 Male patient from UNITED STATES , 56 years of age, was treated with Ethyol (View Usage). Patient had the following side effects: injection site reaction. Ethyol dosage: 1 In 3 Wk, Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

5318077-8 | Fatigue, Injection Site Reaction, Malaise, Pruritus, Pyrexia, Rash Papular, Vomiting
Patient was taking Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: fatigue, injection site reaction, malaise, pruritus, pyrexia, rash papular, vomiting on Mar 02, 2006 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 204.0 lb, . Ethyol dosage: See Image. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ZOFRAN (View Zofran Review and Zofran Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.

5318076-6 | Anaphylactic Reaction, Dyspnoea, Nausea, Pruritus, Urticaria, Wheezing
Adverse event was reported on Feb 21, 2006 by a Female patient taking Ethyol (View Usage) (Dosage: 5 In 1 Wk, Subcutaneous) . Location: UNITED STATES , 59 years of age, weighting 211.0 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, dyspnoea, nausea (What is nausea?), pruritus, urticaria, wheezing. During the same period patient was treated with CARDIZEM (View Cardizem Review and Cardizem Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), BENADRYL (View Benadryl Review and Benadryl Label ), MAALOX (MAGNESIUM HYDROXIDE, ALUMINIUM HYDROXIDE GEL) (View Maalox (magnesium Hydroxide, Aluminium Hydroxide Gel) Review and Maalox (magnesium Hydroxide, Aluminium Hydroxide Gel) Label ). Patient was hospitalized.

5318075-4 | Injection Site Reaction, Malaise, Nikolsky's Sign, Pharyngolaryngeal Pain, Pruritus, Rash, Skin Injury
on Feb 15, 2006 Male patient from UNITED STATES , 48 years of age, weighting 199.6 lb, was treated with Ethyol (View Usage). Patient had the following side effects: injection site reaction, malaise, nikolsky's sign, pharyngolaryngeal pain, pruritus, rash (What is rash?), skin injury. Ethyol dosage: Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ATIVAN (View Ativan Review and Ativan Label ), LORA TAB (View Lora Tab Review and Lora Tab Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ).

5318066-3 | Constipation, Dehydration, Fluid Intake Reduced, Injection Site Rash, Malaise, Nausea, Pharyngolaryngeal Pain
on Jan 12, 2006 Female patient from UNITED STATES , 70 years of age, weighting 153.6 lb, was treated with Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: constipation (What is constipation?), dehydration, fluid intake reduced, injection site rash, malaise, nausea (What is nausea?), pharyngolaryngeal pain. Ethyol dosage: 5 In 1 Wk, Subcutaneous. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CLARITIN (View Claritin Review and Claritin Label ). Patient was hospitalized.

5318059-6 | Diarrhoea, Injection Site Erythema, Lethargy, Malaise, Nikolsky's Sign, Rash Papular, Skin Burning Sensation, Skin Injury
Patient was taking Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, injection site erythema, lethargy, malaise, nikolsky's sign, rash papular, skin burning sensation, skin injury on Jan 06, 2006 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 168.0 lb, . Ethyol dosage: 5 In 1 Wk, Subcutaneous. During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), CLARITIN (View Claritin Review and Claritin Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

5318056-0 | Epistaxis, Erythema, Erythema Multiforme, Injection Site Erythema, Injection Site Rash, Pharyngolaryngeal Pain, Pruritus, Skin Burning Sensation
Adverse event was reported on Dec 21, 2005 by a Male patient taking Ethyol (View Usage) (Dosage: Subcutaneous) . Location: UNITED STATES , 51 years of age, weighting 300.5 lb, Patient had the following side effects: epistaxis, erythema, erythema multiforme, injection site erythema, injection site rash, pharyngolaryngeal pain, pruritus, skin burning sensation. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), HYDROCODONE (HYDROCODONE) (View Hydrocodone (hydrocodone) Review and Hydrocodone (hydrocodone) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ZOFRAN (View Zofran Review and Zofran Label ).

5310177-1 | Adhesion, Agranulocytosis, Blood Culture Positive, Bronchial Injury, Bronchial Obstruction, Cardiac Failure, Catheter Related Infection, Conjunctival Oedema, Corneal Disorder
on Apr 12, 2007 Male patient from FRANCE , 68 years of age, was diagnosed with prophylaxis and was treated with Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: adhesion (What is adhesion?), agranulocytosis, blood culture positive, bronchial injury, bronchial obstruction, cardiac failure, catheter related infection, conjunctival oedema, corneal disorder. Ethyol dosage: 340 Mg, 3 In 1 Wk, Intravenous. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ZALDIAR (PARACETAMOL, TRAMADOL HYDROCHLORIDE) (View Zaldiar (paracetamol, Tramadol Hydrochloride) Review and Zaldiar (paracetamol, Tramadol Hydrochloride) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5310176-X | Coagulation Factor Decreased, Haemoglobin Decreased, Lymphopenia, Prothrombin Time Prolonged, Stevens-johnson Syndrome
on Apr 16, 2007 Male patient from FRANCE , 54 years of age, was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation factor decreased, haemoglobin decreased, lymphopenia, prothrombin time prolonged, stevens-johnson syndrome. Ethyol dosage: . Patient was hospitalized.

5309220-5 | Chills, Dehydration, Eye Discharge, Haemoglobin Decreased, Heart Rate Increased, Hypoaesthesia Facial, Injection Site Erythema, Mucosal Inflammation
Patient was taking Ethyol (View Usage). Patient had the following side effects: chills, dehydration, eye discharge, haemoglobin decreased, heart rate increased, hypoaesthesia facial, injection site erythema, mucosal inflammation on Apr 13, 2007 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 183.0 lb, was diagnosed with prophylaxis and. Ethyol dosage: 400 Mg, 1 In 1d, Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), LASIX (View Lasix Review and Lasix Label ), DOLASETRON (DOLASETRON) (View Dolasetron (dolasetron) Review and Dolasetron (dolasetron) Label ), DECADRON (View Decadron Review and Decadron Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5298477-5 | Febrile Neutropenia, Oxygen Saturation Decreased, Septic Shock, Tachycardia, Vomiting
Adverse event was reported on Mar 27, 2007 by a Male patient taking Ethyol (View Usage) (Dosage: See Image) . Location: UNITED STATES , 43 years of age, After Ethyol was administered, patient had the following side effects: febrile neutropenia, oxygen saturation decreased, septic shock, tachycardia, vomiting. During the same period patient was treated with RADIATION (View Radiation Review and Radiation Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), 5 FLUROURACIL (FLUOROURACIL) (View 5-flurouracil (fluorouracil) Review and 5-flurouracil (fluorouracil) Label ), ANZEMET (View Anzemet Review and Anzemet Label ), IMITREX (View Imitrex Review and Imitrex Label ). Patient was hospitalized.

5298476-3 | Candidiasis, Chills, Computerised Tomogram Abnormal, Dry Throat, Eye Discharge, Haemoglobin Decreased, Hypoaesthesia Facial, Injection Site Erythema
on Mar 29, 2007 Male patient from UNITED STATES , 51 years of age, weighting 183.0 lb, was diagnosed with prophylaxis and was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: candidiasis, chills, computerised tomogram abnormal, dry throat, eye discharge, haemoglobin decreased, hypoaesthesia facial, injection site erythema. Ethyol dosage: 400 Mg, 1 In 1 D, Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), LASIX (View Lasix Review and Lasix Label ), DOLASETRON (DOLASETRON) (View Dolasetron (dolasetron) Review and Dolasetron (dolasetron) Label ), DECADRON (View Decadron Review and Decadron Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5298475-1 | Dehydration, Dyspnoea, Injection Site Discolouration, Injection Site Erythema, Injection Site Rash, Injection Site Reaction, Oxygen Saturation Decreased, Pharyngolaryngeal Pain
on Mar 27, 2007 Female patient from UNITED STATES , 71 years of age, was treated with Ethyol (View Usage). Patient had the following side effects: dehydration, dyspnoea, injection site discolouration, injection site erythema, injection site rash, injection site reaction, oxygen saturation decreased, pharyngolaryngeal pain. Ethyol dosage: 500 Mg, 5 In 5 D, Subcutaneous. During the same period patient was treated with CARBOTAXOL (PACLITAXEL, CARBOPLATIN) (View Carbotaxol (paclitaxel, Carboplatin) Review and Carbotaxol (paclitaxel, Carboplatin) Label ), ZOFRAN (View Zofran Review and Zofran Label ).

5298474-X | Erythema, Finger Amputation, Neoplasm Recurrence, Oedema Peripheral, Pain In Extremity, Pyrexia, Secretion Discharge, Skin Discolouration, Skin Ulcer
Patient was taking Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: erythema, finger amputation, neoplasm recurrence, oedema peripheral, pain in extremity, pyrexia, secretion discharge, skin discolouration, skin ulcer on Mar 27, 2007 from UNITED STATES Additional patient health information: Male patient , 53 years of age, weighting 180.0 lb, was diagnosed with neoplasm malignant and. Ethyol dosage: 500 Mg, 5 In 5 D, Subcutaneous. During the same period patient was treated with ERBITUX (Intravenous (not Otherwise Specified)) (View Erbitux Review and Erbitux Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), PROTONIX (View Protonix Review and Protonix Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

5297712-7 | Acute Myocardial Infarction, Aortic Arteriosclerosis, Arteriosclerosis Coronary Artery, Back Pain, Intracardiac Thrombus, Ventricular Fibrillation
Adverse event was reported on Mar 28, 2007 by a Male patient taking Ethyol (View Usage) (Dosage: Intravenous (not Otherwise Specified)) . Location: GERMANY , 54 years of age, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, aortic arteriosclerosis, arteriosclerosis coronary artery, back pain (What is back pain?), intracardiac thrombus, ventricular fibrillation.

5290248-9 | Acute Myocardial Infarction, Alanine Aminotransferase Increased, Anaemia, Arterial Insufficiency, Arteriosclerosis, Aspartate Aminotransferase Increased, Aspiration, Back Pain, Blood Culture Positive
on Mar 22, 2007 Male patient from UNITED STATES , 73 years of age, was treated with Ethyol (View Usage). Patient had the following side effects: acute myocardial infarction, alanine aminotransferase increased, anaemia, arterial insufficiency, arteriosclerosis, aspartate aminotransferase increased, aspiration, back pain (What is back pain?), blood culture positive. Ethyol dosage: 500 Mg, 5 In 5 D, Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ZOFRAN (View Zofran Review and Zofran Label ), DECADRON (View Decadron Review and Decadron Label ), PROCHLORPERAZINE MALEATE (View Prochlorperazine Maleate Review and Prochlorperazine Maleate Label ). Patient was hospitalized.

5286967-0 | Myocardial Infarction
on Mar 20, 2007 Male patient from NETHERLANDS , 54 years of age, was treated with Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: myocardial infarction. Ethyol dosage: Intravenous (not Otherwise Specified).

5285901-7 | Blood Calcium Decreased, Blood Chloride Decreased, Blood Glucose Increased, Blood Potassium Decreased, Blood Sodium Decreased, Blood Urea Decreased, Dehydration, Lip Swelling
Patient was taking Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: blood calcium decreased, blood chloride decreased, blood glucose increased, blood potassium decreased, blood sodium decreased, blood urea decreased, dehydration, lip swelling on Mar 16, 2007 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 169.4 lb, was diagnosed with neoplasm malignant and. Ethyol dosage: 250 Mg, 5 In 5 D, Intramuscular. During the same period patient was treated with ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), TYLENOL (View Tylenol Review and Tylenol Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

5281119-2 | Bleeding Time Prolonged, Blood Fibrinogen Abnormal, Haemoglobin Decreased, Kaolin Cephalin Clotting Time Abnormal, Lymphocyte Count Decreased, Lymphopenia, Neutrophil Count Decreased, Stevens-johnson Syndrome
Adverse event was reported on Mar 08, 2007 by a Male patient taking Ethyol (View Usage) (Dosage: ) . Location: FRANCE , 54 years of age, Patient had the following side effects: bleeding time prolonged, blood fibrinogen abnormal, haemoglobin decreased, kaolin cephalin clotting time abnormal, lymphocyte count decreased, lymphopenia, neutrophil count decreased, stevens-johnson syndrome. Patient was hospitalized.

5279699-6 | Abdominal Wall Abscess, Asthenia, Cellulitis, Chills, Dehydration, Electrolyte Imbalance, Feeding Tube Complication, Hypotension, Lethargy
on Mar 14, 2007 Male patient from UNITED STATES , 48 years of age, weighting 330.5 lb, was treated with Ethyol (View Usage). After Ethyol was administered, patient had the following side effects: abdominal wall abscess, asthenia, cellulitis (What is cellulitis?), chills, dehydration, electrolyte imbalance, feeding tube complication, hypotension, lethargy. Ethyol dosage: See Image. During the same period patient was treated with COMPAZINE (View Compazine Review and Compazine Label ), MORPHINE ER (MORPHINE) (View Morphine Er (morphine) Review and Morphine Er (morphine) Label ), REGLAN (View Reglan Review and Reglan Label ). Patient was hospitalized.

5270457-5 | Blood Creatine Increased, Blood Glucose Increased, Chest Discomfort, Chills, Heart Rate Increased, Hypotension, Injection Site Erythema, Pyrexia, Respiratory Failure
on Mar 02, 2007 Male patient from UNITED STATES , 65 years of age, was diagnosed with prophylaxis and was treated with Ethyol (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine increased, blood glucose increased, chest discomfort, chills, heart rate increased, hypotension, injection site erythema, pyrexia, respiratory failure. Ethyol dosage: 500 Mg, 5 In 5, Subcutaneous. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOL (View Taxol Review and Taxol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ). Patient was hospitalized.

5266951-3 | Arthralgia, Bladder Cancer, Diarrhoea, Injection Site Erythema, Injection Site Irritation, Injection Site Papule, Injection Site Reaction, Metastases To Bone, Metastases To Liver
Patient was taking Ethyol (View Usage). Patient had the following side effects: arthralgia, bladder cancer (What is bladder cancer?), diarrhoea, injection site erythema, injection site irritation, injection site papule, injection site reaction, metastases to bone, metastases to liver on Feb 27, 2007 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 136.0 lb, . Ethyol dosage: 500 Mg, 5 In 5 D, Subcutaneous. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), GEMCITABINE (CEMCITABINE) (View Gemcitabine (cemcitabine) Review and Gemcitabine (cemcitabine) Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.